Europe Small Molecule Contract Development and Manufacturing Organization (CDMO) Markets 2022-2031: Increasing Demand for Small Molecule Medicines and Therapies & Rising Demand for Cost Control

News provided by

Jan 31, 2023, 18:00 ET

DUBLIN, Jan. 31, 2023 /PRNewswire/ -- The "Europe Small Molecule Contract Development and Manufacturing Organization Market 2021-2031 by Product Type, Service Type, Customer Type, Therapeutic Area, and Country: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

Europe small molecule contract development and manufacturing organization (CDMO) market was valued at $ 17,340.6 million in 2021 and will grow by 6.2% annually over 2021-2031.

The market is driven by the increasing demand for small molecule medicines and therapies, a rising demand for cost control in drug development, the increasing incidence of disease, and rising healthcare expenditures.

Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Boehringer Ingelheim
Cambrex Corporation
Catalent
Cipla
Covance Inc.
Lonza Group Ltd.
Medley Pharmaceuticals
NatcoPharma
Patheon (Thermo Fisher Scientific, Inc.)
Piramal Pharma Solutions
RedHillBiopharma
Siegfried Holding AG
STA Pharmaceutical
Sun Pharmaceutical
Teva

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porter's Fiver Forces

Scope of the Report

Active Pharmaceutical Ingredients (API)

Branded Drugs
Generic Drugs

Finished Dosage Formulations (FDF)

Oral Solid Drugs
Injectable Drugs
Semi-solid or Liquid Drugs
Other FDFs

Based on Service Type

Preclinical Use
Clinical Use
Phase I
Phase II
Phase III
Phase IV
Commercial Use

By Customer Type

Pharmaceutical Firms
Biotechnology Firms

By Therapeutic Area

Infectious Diseases
Oncology
Ophthalmology
Cardiovascular Disorders
Central Nervous System
Respiratory Disorders
Metabolic Diseases
Other Therapeutic Areas

Geographically, the following national/local markets are fully investigated:

Germany
UK
France
Spain
Italy
Netherlands
Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

For more information about this report visit https://www.researchandmarkets.com/r/e853cn-small?w=5

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets